158 related articles for article (PubMed ID: 8278024)
1. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
Lane RJ; McLean KA; Moss J; Woodrow DF
Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
[TBL] [Abstract][Full Text] [Related]
2. Prognosis in AZT myopathy.
Chalmers AC; Greco CM; Miller RG
Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
Pezeshkpour G; Illa I; Dalakas MC
Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434
[TBL] [Abstract][Full Text] [Related]
4. HIV or zidovudine myopathy?
Gherardi R; Chariot P
Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
[No Abstract] [Full Text] [Related]
5. HIV or zidovudine myopathy?
Dalakas M
Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
[No Abstract] [Full Text] [Related]
6. 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients.
Weissman JD; Constantinitis I; Hudgins P; Wallace DC
Neurology; 1992 Mar; 42(3 Pt 1):619-23. PubMed ID: 1549225
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
[TBL] [Abstract][Full Text] [Related]
8. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
Schröder JM; Bertram M; Schnabel R; Pfaff U
Acta Neuropathol; 1992; 85(1):39-47. PubMed ID: 1285495
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial myopathy caused by long-term zidovudine therapy.
Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
Chariot P; Bonne G; Authier FJ; Marsac C; Gherardi R
J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166
[TBL] [Abstract][Full Text] [Related]
12. HIV or zidovudine myopathy?
Grau JM; Casademont J
Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309595
[No Abstract] [Full Text] [Related]
13. Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers.
Gherardi RK; Florea-Strat A; Fromont G; Poron F; Sabourin JC; Authier J
Ann Neurol; 1994 Nov; 36(5):752-8. PubMed ID: 7979221
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle involvement in HIV-infected patients.
Gherardi RK
Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
Morgello S; Wolfe D; Godfrey E; Feinstein R; Tagliati M; Simpson DM
Acta Neuropathol; 1995; 90(4):366-74. PubMed ID: 8546027
[TBL] [Abstract][Full Text] [Related]
16. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
[TBL] [Abstract][Full Text] [Related]
17. Zidovudine-associated myopathy.
Paradis J; Calis KA
Am J Hosp Pharm; 1994 Dec; 51(24):3026-8. PubMed ID: 7856620
[No Abstract] [Full Text] [Related]
18. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
Chariot P; Monnet I; Gherardi R
Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.
Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M
Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882
[TBL] [Abstract][Full Text] [Related]
20. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]